- Home
- BHVN vs FRPT Comparison
BHVN vs FRPT Comparison
Compare BHVN & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- FRPT
- Stock Information
- Founded
- BHVN 2013
- FRPT 2004
- Country
- BHVN United States
- FRPT United States
- Employees
- BHVN N/A
- FRPT N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- FRPT Packaged Foods
- Sector
- BHVN Health Care
- FRPT Consumer Staples
- Exchange
- BHVN Nasdaq
- FRPT Nasdaq
- Market Cap
- BHVN 5.4B
- FRPT 6.5B
- IPO Year
- BHVN 2017
- FRPT 2014
- Fundamental
- Price
- BHVN $45.17
- FRPT $156.57
- Analyst Decision
- BHVN Strong Buy
- FRPT Strong Buy
- Analyst Count
- BHVN 13
- FRPT 15
- Target Price
- BHVN $63.42
- FRPT $160.13
- AVG Volume (30 Days)
- BHVN 729.5K
- FRPT 600.5K
- Earning Date
- BHVN 11-12-2024
- FRPT 11-04-2024
- Dividend Yield
- BHVN N/A
- FRPT N/A
- EPS Growth
- BHVN N/A
- FRPT N/A
- EPS
- BHVN N/A
- FRPT 0.88
- Revenue
- BHVN N/A
- FRPT $927,890,000.00
- Revenue This Year
- BHVN N/A
- FRPT $29.88
- Revenue Next Year
- BHVN $179.00
- FRPT $24.59
- P/E Ratio
- BHVN N/A
- FRPT $176.60
- Revenue Growth
- BHVN N/A
- FRPT 29.36
- 52 Week Low
- BHVN $26.80
- FRPT $68.22
- 52 Week High
- BHVN $62.21
- FRPT $159.12
- Technical
- Relative Strength Index (RSI)
- BHVN 38.20
- FRPT 64.27
- Support Level
- BHVN $43.18
- FRPT $148.84
- Resistance Level
- BHVN $54.53
- FRPT $157.95
- Average True Range (ATR)
- BHVN 2.57
- FRPT 5.42
- MACD
- BHVN -0.85
- FRPT 0.33
- Stochastic Oscillator
- BHVN 16.86
- FRPT 89.26
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.